Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 12.3M | 17.2M | 12.6M | 6.4M |
| Cost of revenue | 3.8M | 5.6M | 3.7M | 2.6M |
| Gross profit | 8.5M | 11.5M | 8.9M | 3.9M |
| Operating expense | ||||
| Research & development | 5.2M | 4.3M | 2.9M | 3.8M |
| Selling general and admin | 21.5M | 21.4M | 12.2M | 13.5M |
| Other operating expenses | 151K | 255K | 398K | 328K |
| Operating income | -18.0M | -13.7M | -6.4M | -13.5M |
| Non operating interest income | ||||
| Income | 355K | 519K | 59K | 19K |
| Expense | 597K | 132K | 551K | 436K |
| Other income expense | — | — | — | — |
| Pretax income | -18.2M | -13.3M | -6.9M | -13.9M |
| Tax provision | -229K | -41K | 334K | -145K |
| Net income | -18.0M | -13.3M | -7.2M | -13.8M |
| Basic EPS | -0.1 | -0.1 | 0.0 | -0.1 |
| Diluted EPS | -0.1 | -0.1 | 0.0 | -0.1 |
| Basic average shares | 242.7M | 242.7M | 187.5M | 187.5M |
| Diluted average shares | 242.7M | 242.7M | 187.5M | 187.5M |
| EBITDA | -17.6M | -13.2M | -6.4M | -13.5M |
| Net income from continuing op. | -18.0M | -13.7M | -6.4M | -13.5M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |